You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T1a tumours

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

Completed
  • Gastrointestinal Tumor
  • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
  • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
  • Hangzhou, China
    Zhejiang Hospital
Sep 1, 2023

Cancer: Recurrent and/or Metastatic Solid Tumours Trial in Edmonton (CCI-001)

Recruiting
  • Cancer: Recurrent and/or Metastatic Solid Tumours
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jul 12, 2022

Solid Tumors Trial in Canada, United Kingdom (cediranib)

Active, not recruiting
  • Solid Tumors
  • Edmonton, Alberta, Canada
  • +4 more
Sep 20, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)

Withdrawn
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jul 7, 2022

Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)

Active, not recruiting
  • Advanced Rare Tumours
  • Calgary, Alberta, Canada
  • +16 more
Mar 17, 2022

Advanced Rare Tumours Trial in Canada (Durvalumab, Tremelimumab)

Active, not recruiting
  • Advanced Rare Tumours
  • Edmonton, Alberta, Canada
  • +12 more
Jan 25, 2022

Advanced and/or Metastatic Solid Tumours Trial in Netherlands, United Kingdom (CB307)

Recruiting
  • Advanced and/or Metastatic Solid Tumours
  • Amsterdam, Noord-Holland, Netherlands
  • +9 more
Apr 21, 2022

Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

Active, not recruiting
Has Results
  • Non Small Cell Lung Cancer
  • La Jolla, California
  • +43 more
Nov 25, 2022

Neuroendocrine Tumors Trial in Edmonton ([68]Ga-HA-DOTATATE)

Recruiting
  • Neuroendocrine Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jun 18, 2021

Advanced Solid Tumours Trial (EBC-129, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumours
  • (no location specified)
Jan 18, 2023

Clear Cell Renal Cell Cancer, Non-Small-Cell Lung Cancer, Triple Negative Breast Tumors Trial in Worldwide (AZD8701, Durvalumab)

Recruiting
  • Clear Cell Renal Cell Cancer
  • +8 more
  • La Jolla, California
  • +22 more
Aug 12, 2022

Carcinoma, Neuroendocrine Trial in Edmonton ([177]Lu-DOTA-TATE)

Recruiting
  • Carcinoma, Neuroendocrine
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Apr 12, 2021

Solid Tumor Trial in Barcelona, Madrid (OMX-0407)

Recruiting
  • Solid Tumor
  • Barcelona, Spain
  • +1 more
Apr 28, 2023

Locally Advanced or Metastatic Solid Tumours Trial in Worldwide (AZD0171, Durvalumab, Gemcitabine)

Recruiting
  • Locally Advanced or Metastatic Solid Tumours
  • Scottsdale, Arizona
  • +46 more
Jun 13, 2022

Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

Not yet recruiting
  • Cancer
  • [177Lu]Lu-PSMA I&T
  • Meldola, Forlì, Italy
  • +1 more
May 10, 2023

Advanced Solid Tumours Trial in Belgium, France (EXS21546)

Recruiting
  • Advanced Solid Tumours
  • Brussels, Belgium
  • +4 more
Jun 26, 2023

Advanced Solid Tumours Trial (PM1021, PM8001)

Not yet recruiting
  • Advanced Solid Tumours
  • PM1021, PM8001
  • (no location specified)
Sep 12, 2022

3T MRI of Intramedullary Spinal Cord Tumours

Recruiting
  • Spinal Cord Tumor of Cervical Spine
  • MRI scan
  • Oxford, Oxfordshire, United Kingdom
    John Radcliffe Hospital
Dec 15, 2022

Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • (no location specified)
Jan 28, 2023

Oncology Trial in Brisbane, Adelaide (SUPLEXA)

Recruiting
  • Oncology
  • SUPLEXA
  • Brisbane, Queeensland, Australia
  • +2 more
Dec 16, 2022

PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS Trial (blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor

Not yet recruiting
  • PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
  • blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.
  • (no location specified)
Aug 17, 2023

Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +6 more
  • Omaha, Nebraska
    Urology Cancer Center/XCancer
Nov 29, 2022

Advanced Solid Tumors, NSCLC, Triple-negative Breast Cancer Trial in Barcelona, Madrid (OMO-103)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • OMO-103
  • Barcelona, Spain
  • +2 more
Sep 27, 2022

Advanced/Metastatic Solid Tumours Trial in Canada (MG1MA3, AdMA3)

Active, not recruiting
  • Advanced/Metastatic Solid Tumours
  • MG1MA3
  • AdMA3
  • Vancouver, British Columbia, Canada
  • +3 more
Jan 30, 2023

Solid Tumor, Adult Trial in Belgium, France (DT-9081 - dose escalation, DT-9081 - expansion)

Recruiting
  • Solid Tumor, Adult
  • DT-9081 - dose escalation
  • DT-9081 - expansion
  • Anderlecht, Belgium
  • +3 more
Jan 5, 2023